Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Cardiac Troponin Market Outlook

The global cardiac troponin market is expected to grow at a CAGR of about 8.00% in the forecast period of 2024-2032, driven by the rising cases of heart failure.

cardiac troponin market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to be a Significant Regional Market for Cardiac Troponin

North America is anticipated to dominate the global cardiac troponin industry in the forecast period. Heart failure is a critical healthcare issue in the United States. It is highly prevalent and has high mortality and morbidity rate. The cost of care for heart diseases is high in the United States. The prevalence of heart failure in the country is expected to increase with an increasingly ageing population, driving the market growth in the region.

The market is also growing due to high expenditure on research and development, major players and their product availability, and the well-established healthcare infrastructure in the region. The increase aids the demand for cardiac biomarkers for cardiovascular disease diagnosis, a rise in the incidence of the acute coronary syndrome (ACS), advancements in the treatment, and growth in demand for point-of-care cardiac testing kits. The key market players' high specificity and sensitivity of these markers to detect cardiac disorders also contribute to the market growth.

Market Segmentations

cardiac troponin market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Troponin, a key regulatory protein of striated muscle's thin filament (actin), comprises three subunits: C, T, and I. Cardiovascular troponins are biomarkers or diagnostic markers used to detect myocardial infarction. Cardiac troponin is found in both skeletal and cardiac muscles, and a rise in cardiac troponin levels in the blood indicates the onset of myocardial infarction.

By type, the market includes:

  • Troponin T
  • Troponin I

Based on the site of testing, the market is divided into:

  • Laboratory Testing
  • Point-of-care Testing

The major applications of the market are:

  • Acute Coronary Syndrome
  • Myocardial Infarction
  • Congestive Heart Failure
  • Others

The end-uses of the market include:

  • Hospitals
  • Diagnostic Centres
  • Homecare Settings
  • Others

The several distribution channels of the market are:

  • Manufacturer/ Distributor/ Service Provider
  • Aftermarket

cardiac troponin market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The regional markets for the cardiac troponin industry can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

Rising Demand for Cardiac Biomarkers to Diagnose Cardiovascular Diseases Augmenting the Market Growth

The global cardiac troponin industry is driven by the rising demand for cardiac biomarkers to diagnose cardiovascular diseases, the increasing prevalence of acute coronary syndrome, and the reduction in the burden of healthcare costs due to faster and acute diagnosis. Patients suffering from acute critical heart conditions require immediate results and quick diagnosis to avoid any causalities. Hence, physicians and doctors demand advanced use of cardiac troponins, pushing researchers and major companies to make investments. Major companies are focusing on the research and development of cardiac troponin tests and are aiming for the approval of new products to retain and enhance market competitiveness. For instance, in June 2018, Beckman Coulter Diagnostics received Health Canada clearance for its new high sensitivity troponin (hsTnI) assay, Access hsTnI, that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms.

Besides this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. An increase in the geriatric population and a rise in the number of patients suffering from heart attacks and chest pain due to lifestyle changes are expected to drive the market in the coming years.

Key Players in the Global Cardiac Troponin Market

The report gives a detailed analysis of the following key players in the global cardiac troponin industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • Eurolyser Diagnostica GmbH
  • Beckman Coulter, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Site of Testing
  • Application
  • End-Use
  • Distribution Channel
  • Region
Breakup by Type
  • Troponin T
  • Troponin I
Breakup by Site of Testing
  • Laboratory Testing
  • Point-of-care Testing
Breakup by Application
  • Acute Coronary Syndrome
  • Myocardial Infarction
  • Congestive Heart Failure
  • Others
Breakup by End-Use
  • Hospitals
  • Diagnostic Centres
  • Homecare Settings
  • Others
Breakup by Distribution Channel
  • Manufacturer/ Distributor/ Service Provider
  • Aftermarket
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • Eurolyser Diagnostica GmbH
  • Beckman Coulter, Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The global cardiac troponin market will grow at a CAGR of 8.00% between 2024 and 2032.

The major drivers of the market include the reduction in the burden of healthcare costs, increasing investments, growing research and development activities, approval of new products, rising awareness among patients and healthcare providers, increase in the geriatric population, rise in the number of patients suffering from heart attacks and chest pain, and changes in lifestyles.

The rising demand for cardiac biomarkers to diagnose cardiovascular diseases and the increasing prevalence of acute coronary syndrome are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Troponin T and troponin I are the different types of cardiac troponins in the market.

Based on the testing site, the market is divided into laboratory testing and point-of-care testing.

The major applications of the market are acute coronary syndrome, myocardial infarction, and congestive heart failure, among others.

The end-uses of the market include hospitals, diagnostic centres, and homecare settings, among others.

The several distribution channels of the market are manufacturer/ distributor/ service provider and aftermarket.

The major players in the industry are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Eurolyser Diagnostica GmbH, and Beckman Coulter, Inc., among others.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124